Loading...

Gilead Sciences, Inc.

GILD•NASDAQ
Healthcare
Drug Manufacturers - General
$130.40
$-3.24(-2.42%)
U.S. Market opens in 15h 23m

Gilead Sciences, Inc. (GILD) Stock Overview

Explore Gilead Sciences, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap161.7B
P/E Ratio18.99
EPS (TTM)$8.15
ROE0.41%
Fundamental Analysis

AI Price Forecasts

1 Month$138.31
3 Months$143.97
1 Year Target$163.80

GILD Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Gilead Sciences, Inc. (GILD) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 30.11, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $163.80.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 18.99 and a market capitalization of 161.7B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-2.42%
5-Day Change
-6.15%
1-Month Change
-5.58%
3-Month Change
-4.07%
6-Month Change
7.82%
Year-to-Date (YTD) Change
6.24%
1-Year Change
22.85%
3-Year Change
50.40%
5-Year Change
98.30%
All-Time (Max) Change
20506.50%

Contact Information

https://www.gilead.com
650 574 3000
333 Lakeside Drive, Foster City, CA, 94404

Company Facts

17,600 Employees
IPO DateJan 22, 1992
CountryUS
Actively Trading

Frequently Asked Questions